Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Expanding applications: GLP-1s are now being explored beyond metabolic diseases, including liver disease (e.g., MASH/NAFLD), cardiovascular health, sleep apnea, alcohol use disorder, and potentially reducing obesity-related cancer risk
Its the first oral GLP-1 medication to receive FDA approval for weight management
FDA-approved GLP-1 and related medications have changed the weight loss conversation because they can help eligible patients reduce excess body weight when used alongside nutrition, physical activity, and medical oversight
Research involving Ipamorelin and Hexarelin has helped expand scientific knowledge in areas such as: Growth hormone receptor signaling G protein-coupled receptor (GPCR) biology Endocrine physiology Peptide pharmacology Cellular communication Hormone regulation Experimental peptide design These studies continue to improve our understanding of how growth hormone secretagogues interact with the endocrine system and how receptor-mediated signaling influences biological processes
